FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Some of FDC’s leading brands in India include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zathrin, Zipod, Cotaryl and Mycoderm in the domestic and international markets.
Financial Results:
FDC Ltd reported Revenues for Q2FY24 of ₹486.00 Crores up from ₹445.00 Crore year on year, a rise of 9.21%.
Total Expenses for Q2FY24 of ₹421.00 Crores up from ₹389.00 Crores year on year, a rise of 8.23%.
Consolidated Net Profit of ₹70.00 Crores up 34.62% from ₹52.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.21, up 34.94% from ₹3.12 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.